Literature DB >> 11873254

Evaluation of IFN-gamma and TNF-alpha as immunological markers of clinical outcome in cutaneous leishmaniasis.

Argemiro D'Oliveira1, Paulo Machado, Olívia Bacellar, Lay Har Cheng, Roque P Almeida, Edgar M Carvalho.   

Abstract

To evaluate if IFN-gamma and TNF-alpha levels could be used as markers of therapeutic response in cutaneous leishmaniasis, 54 patients with history of one ulcerated cutaneous lesion, with up to 30 days onset, were enrolled in the study. IFN-gamma and TNF-alpha were measured by ELISA in lymphocyte cultures supernatant before and 60 days after initiating therapy. Cure was considered to be a complete healing of lesion 60 days after treatment. IFN-gamma and TNF-alpha levels were similar in both groups of patients before therapy. There was a tendency to increase IFN-gamma levels in patients that were cured in 60 days, however the values did not reach statistical significance. In both groups of patients, TNF-alpha levels were similar before therapy and fell significantly after treatment, irrespective of cure or maintenance of active lesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873254     DOI: 10.1590/s0037-86822002000100002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  11 in total

1.  FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.

Authors:  L Castellucci; S E Jamieson; E N Miller; L F de Almeida; J Oliveira; A Magalhães; L H Guimarães; M Lessa; E Lago; A R de Jesus; E M Carvalho; J M Blackwell
Journal:  Genes Immun       Date:  2011-06-02       Impact factor: 2.676

2.  Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline.

Authors:  Graça Brito; Mayra Dourado; Ludmila Polari; Daniela Celestino; Lucas P Carvalho; Adriano Queiroz; Edgar M Carvalho; Paulo R L Machado; Sara Passos
Journal:  Am J Trop Med Hyg       Date:  2014-02-24       Impact factor: 2.345

3.  Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis.

Authors:  Fabiano Oliveira; Andre Bafica; Andrea B Rosato; Cecilia B F Favali; Jackson M Costa; Virginia Cafe; Manoel Barral-Netto; Aldina Barral
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

4.  Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.

Authors:  Arturo A Wilkins-Rodríguez; Armando Pérez-Torres; Alma R Escalona-Montaño; Laila Gutiérrez-Kobeh
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 5.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

Review 6.  Potential biomarkers of immune protection in human leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Ali Khamesipour
Journal:  Med Microbiol Immunol       Date:  2021-05-02       Impact factor: 3.402

7.  Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis.

Authors:  Taís M Campos; Sara T Passos; Fernanda O Novais; Daniel P Beiting; Rúbia S Costa; Adriano Queiroz; David Mosser; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2014-11-13

Review 8.  Cytotoxic activity in cutaneous leishmaniasis.

Authors:  Taís M Campos; Rúbia Costa; Sara Passos; Lucas P Carvalho
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11       Impact factor: 2.743

9.  A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil.

Authors:  Léa C Castellucci; Lucas Almeida; Svetlana Cherlin; Michaela Fakiola; Richard W Francis; Edgar M Carvalho; Anadílton Santos da Hora; Tainã Souza do Lago; Amanda B Figueiredo; Clara M Cavalcanti; Natalia S Alves; Katia L P Morais; Andréa Teixeira-Carvalho; Walderez O Dutra; Kenneth J Gollob; Heather J Cordell; Jenefer M Blackwell
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

10.  American tegumentary leishmaniasis: correlations among immunological, histopathological and clinical parameters.

Authors:  Ana Luiza Grizzo Peres Martins; Jaison Antonio Barreto; José Roberto Pereira Lauris; Ana Claudia Grizzo Peres Martins
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.